Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNU6-701P is a processed pseudogene derived from the U6 small nuclear RNA (snRNA) gene family. The parental U6 snRNA is an essential component of the spliceosome, the molecular machinery responsible for removing introns from pre-mRNA during RNA splicing in the nucleus[1][3]. Pseudogenes like RNU6-701P arise in the genome via retrotransposition (often by L1 elements), generating inactive copies lacking regulatory elements or functional sequence integrity[2]. RNU6-701P does not code for a protein, nor does it act as a functional RNA; it serves as a genomic relic and may be used in research as a marker for retrotransposon activity[2]. There is no evidence for any functionality, involvement in disease, or relevance to drug targeting for this specific pseudogene. Any clinical or therapeutic relevance applies only to the functional U6 snRNA gene, not its pseudogenes[3][1]. If you are seeking a therapeutic, diagnostic, or mechanistic target, this entry is not suitable; it is a pseudogene, not a druggable molecule, receptor, or enzyme. If you need structured information for the functional U6 snRNA, refer to “U6 small nuclear RNA” (also called “U6 snRNA”).
None
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U6 small nuclear 701, pseudogene (RNU6-701P).